Literature DB >> 17038466

Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

D D Gladman1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17038466      PMCID： PMC1798388          DOI： 10.1136/ard.2006.058453

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  25 in total

Review 1.  Psoriatic arthritis and imaging.

Authors:  P A Ory; D D Gladman; P J Mease
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

2.  Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Philip J Mease; Dafna D Gladman; Christopher T Ritchlin; Eric M Ruderman; Serge D Steinfeld; Ernest H S Choy; John T Sharp; Peter A Ory; Renee J Perdok; Mark A Weinberg
Journal:  Arthritis Rheum       Date:  2005-10

3.  Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis.

Authors:  J Husted; D D Gladman; V T Farewell; J A Long
Journal:  J Rheumatol       Date:  1996-06       Impact factor: 4.666

4.  Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis.

Authors:  P Rahman; E Nguyen; C Cheung; C T Schentag; D D Gladman
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

5.  Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.

Authors:  C L Danning; G G Illei; C Hitchon; M R Greer; D T Boumpas; I B McInnes
Journal:  Arthritis Rheum       Date:  2000-06

6.  Hyperuricemia in psoriatic arthritis: prevalence and associated features.

Authors:  I N Bruce; C T Schentag; D D Gladman
Journal:  J Clin Rheumatol       Date:  2000-02       Impact factor: 3.517

7.  Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis.

Authors:  D D Gladman; B Brubacher; D Buskila; P Langevitz; V T Farewell
Journal:  Clin Invest Med       Date:  1993-02       Impact factor: 0.825

8.  Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.

Authors:  M G Blackmore; D D Gladman; J Husted; J A Long; V T Farewell
Journal:  J Rheumatol       Date:  1995-05       Impact factor: 4.666

9.  Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?

Authors:  P S Helliwell; P Hickling; V Wright
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

10.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808
View more
  15 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

Review 2.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 3.  Arthritis mutilans.

Authors:  Amir Haddad; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

Review 4.  Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature.

Authors:  Soumya M Reddy; Sheila Crean; Amber L Martin; Meghan D Burns; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

Review 5.  Psoriatic arthritis: phenotypic variance and nosology.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

6.  The spectrum of psoriatic arthritis in a South African cohort.

Authors:  Jean-Paul Muzemb Kanyik; Annibale Coi; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

Review 7.  Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.

Authors:  Aisha Q Butt; Angela McArdle; David S Gibson; Oliver FitzGerald; Stephen R Pennington
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

8.  Osteoporosis in psoriatic arthritis: is there any?

Authors:  Simeon Grazio; Selma Cvijetić; Tonko Vlak; Frane Grubišić; Valentina Matijević; Tomislav Nemčić; Marija Punda; Zvonko Kusić
Journal:  Wien Klin Wochenschr       Date:  2011-11-29       Impact factor: 1.704

Review 9.  Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.

Authors:  Angela McArdle; Stephen Pennington; Oliver FitzGerald
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

10.  Limited added value of whole spine MRI in spondyloarthritis for disease activity assessment.

Authors:  Ummugulsum Gazel; Gizem Ayan; Dilek Solmaz; Sibel Bakirci; Jacob Karsh; Marcos Sampaio; Zaid Jibri; Sibel Zehra Aydin
Journal:  Clin Rheumatol       Date:  2021-06-29       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.